Against Excess
Drug Policy for Results
Mark Kleiman(Author)
Basic Books (Publisher)
Published on 10. May 1992
Book
Hardback
496 pages
978-0-465-01103-2 (ISBN)
Description
Drug-taking and drug control are alike; both are often done to excess. "Against Excess" shows how we can limit the damage done by drugs and the damage done by drug policies. Mark Kleiman cuts through the rhetoric of the war on drugs and the legalization debate to discuss the practical options available for the control of the entire range of psychoactive substances, offering detailed prescriptions for managing alcohol, nicotine, cocaine, marijuana and heroin. "Against Excess" is organized around 3 questions: Why do some people who can manage the rest of their lives get into trouble with drugs? How do their problems harm their families and their communities? What can governments do about it? Kleiman argues that we need to develop a middle course between prohibition and complete legal availability: a new category of "grudging toleration" that would apply to alcohol and to some of the currently prohibited drugs. He also argues that as a practical matter drug programs - enforcement, persuasion, and helping and controlling problem users - may be as important as the laws.
More details
Language
English
Place of publication
United States
Target group
College/higher education
Professional and scholarly
Illustrations
subject index; name index
Dimensions
Height: 236 mm
Width: 156 mm
ISBN-13
978-0-465-01103-2 (9780465011032)
Copyright in bibliographic data is held by Nielsen Book Services Limited or its licensors: all rights reserved.
Schweitzer Classification
Content
Part 1 Preliminaries: introduction - how to stop losing the war on drugs - thinking about drug policy. Part 2 Problems: drug abuse and other bad habits, the other victims of drug abuse. Part 3 Policies: laws, the markets for illicit drugs, enforcement, persuasion, help, and control. Part 4 Drugs: alcohol, marijuana, cocaine, tobacco, heroin. Part 5 Recapitulation and conclusion: against excess - drug policy in moderation.